2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic.
作者信息
Townsend Julie S
机构信息
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
出版信息
Lancet Oncol. 2023 Aug;24(8):825-826. doi: 10.1016/S1470-2045(23)00337-6.
Abstract
摘要
相似文献
1
2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic.2020年美国癌症发病率数据揭示了新冠疫情的影响。
Lancet Oncol. 2023 Aug;24(8):825-826. doi: 10.1016/S1470-2045(23)00337-6.
2
1 in 9 USA cancer diagnoses missed during 2020 COVID-19 pandemic.在2020年新冠疫情期间，美国每9例癌症诊断中就有1例被漏诊。
Lancet Oncol. 2024 May;25(5):536. doi: 10.1016/S1470-2045(24)00154-2. Epub 2024 Mar 21.
3
New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic.在新冠疫情大流行的第二个完整年份，美国新增癌症诊断病例数仍滞后。
JCO Clin Cancer Inform. 2022 Oct;6:e2200102. doi: 10.1200/CCI.22.00102.
4
Routine cancer screening delays due to pandemic at veteran affairs.退伍军人事务部因疫情导致常规癌症筛查延迟。
J Natl Med Assoc. 2022 Feb;114(1):12-15. doi: 10.1016/j.jnma.2021.08.033. Epub 2021 Sep 8.
5
Trends in Top Cancer Diagnosis and Challenges Related to COVID-19 Pandemic.顶级癌症诊断趋势及与新冠疫情相关的挑战
Am Surg. 2020 Nov;86(11):1515-1517. doi: 10.1177/0003134820949522. Epub 2020 Aug 28.
6
The COVID-19 pandemic and associated declines in cancer incidence by race/ethnicity and census-tract level SES, rurality, and persistent poverty status.新冠疫情以及与之相关的癌症发病率的下降，按种族/民族、普查区社会经济地位、农村地区和持续贫困状况划分。
Cancer Med. 2024 Sep;13(17):e70220. doi: 10.1002/cam4.70220.
7
Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.研究：2020年大流行期间，美国每9例癌症病例中有1例被漏诊。
JAMA. 2024 Apr 2;331(13):1082. doi: 10.1001/jama.2024.4446.
8
Annual Report to the Nation on the Status of Cancer, featuring state-level statistics after the onset of the COVID-19 pandemic.《美国癌症现状年度报告》，重点介绍了新冠疫情爆发后的州级统计数据。
Cancer. 2025 May 1;131(9):e35833. doi: 10.1002/cncr.35833.
9
Changes in cancer incidence rates by stage during the COVID-19 pandemic in the US.美国新冠疫情期间各阶段癌症发病率的变化。
Int J Cancer. 2024 Mar 1;154(5):786-792. doi: 10.1002/ijc.34758. Epub 2023 Nov 16.
10
Alcohol-related harm during the COVID-19 pandemic.2019冠状病毒病疫情期间与酒精相关的危害。
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):511. doi: 10.1016/S2468-1253(21)00185-0.
引用本文的文献
1
Pediatric and Young Adult Cancer Incidence in the United States During the COVID-19 Pandemic.美国新冠疫情期间儿童及青年癌症发病率
Pediatr Blood Cancer. 2025 Aug 20:e31976. doi: 10.1002/pbc.31976.
2
Influence of the COVID-19 pandemic on the incidence and mortality of primary spinal tumors in the United States: A SEER analysis.2019年冠状病毒病大流行对美国原发性脊柱肿瘤发病率和死亡率的影响：一项监测、流行病学和最终结果（SEER）分析
Eur Spine J. 2025 Mar 31. doi: 10.1007/s00586-025-08800-5.
3
Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma.肝内胆管癌的流行病学、生存率及新治疗方式
J Gastrointest Oncol. 2024 Aug 31;15(4):1777-1788. doi: 10.21037/jgo-24-165. Epub 2024 Aug 28.
本文引用的文献
1
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.美国 COVID-19 大流行第一年癌症诊断和分期分布的变化：一项全国性的横断面评估。
Lancet Oncol. 2023 Aug;24(8):855-867. doi: 10.1016/S1470-2045(23)00293-0.
2
Neighborhood deprivation, racial segregation and associations with cancer risk and outcomes across the cancer-control continuum.社区剥夺、种族隔离与癌症风险和癌症防治连续统各阶段结局的关联。
Mol Psychiatry. 2023 Apr;28(4):1494-1501. doi: 10.1038/s41380-023-02006-1. Epub 2023 Mar 3.
3
Mortality in the United States, 2021.2021年美国的死亡率
NCHS Data Brief. 2022 Dec(456):1-8.
4
COVID-19 and Other Underlying Causes of Cancer Deaths - United States, January 2018-July 2022.COVID-19 与其他癌症死亡原因 - 美国，2018 年 1 月-2022 年 7 月。
MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1583-1588. doi: 10.15585/mmwr.mm7150a3.
5
Modifications in Primary Care Clinics to Continue Colorectal Cancer Screening Promotion During the COVID-19 Pandemic.初级保健诊所的调整以在 COVID-19 大流行期间继续促进结直肠癌筛查。
J Community Health. 2023 Feb;48(1):113-126. doi: 10.1007/s10900-022-01154-9. Epub 2022 Oct 29.
6
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.癌症护理在 COVID-19 大流行期间的种族和民族差异。
JAMA Netw Open. 2022 Jul 1;5(7):e2222009. doi: 10.1001/jamanetworkopen.2022.22009.
7
Changes in Cancer Screening in the US During the COVID-19 Pandemic.美国在 COVID-19 大流行期间癌症筛查的变化。
JAMA Netw Open. 2022 Jun 1;5(6):e2215490. doi: 10.1001/jamanetworkopen.2022.15490.
8
COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.2020 年 1 月至 6 月，美国全国乳腺癌和宫颈癌早期检测计划（NBCCEDP）中 COVID-19 对筛查检测量的影响。
Prev Med. 2021 Oct;151:106559. doi: 10.1016/j.ypmed.2021.106559. Epub 2021 Jun 30.
9
Cancer Incidence Projections in the United States Between 2015 and 2050.美国 2015 年至 2050 年癌症发病率预测。
Prev Chronic Dis. 2021 Jun 10;18:E59. doi: 10.5888/pcd18.210006.
10
Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.美国癌症筛查不足与新冠疫情的关联。
JAMA Oncol. 2021 Jun 1;7(6):878-884. doi: 10.1001/jamaoncol.2021.0884.
Zotero 插件